This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.

4gos

From Proteopedia

(Difference between revisions)

Jump to: navigation, search

Current revision

Crystal structure of human B7-H4 IgV-like domain

Structural highlights

4gos is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance.
Ligands:	, ,
Resources:	FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT

Function

VTCN1_HUMAN Negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. When expressed on the cell surface of tumor macrophages, plays an important role, together with regulatory T-cells (Treg), in the suppression of tumor-associated antigen-specific T-cell immunity. Involved in promoting epithelial cell transformation.^[1] ^[2] ^[3] ^[4] [UniProtKB:Q7TSP5]

Publication Abstract from PubMed

B7x (B7-H4 or B7S1) is a member of the B7 family that can inhibit T cell function. B7x protein is absent in most normal human tissues and immune cells, but it is overexpressed in human cancers and often correlates with negative clinical outcome. The expression pattern and function of B7x suggest that it may be a potent immunosuppressive pathway in human cancers. Here, we determined the crystal structure of the human B7x immunoglobulin variable (IgV) domain at 1.59 A resolution and mapped the epitopes recognized by monoclonal antibodies. We developed an in vivo system to screen therapeutic monoclonal antibodies against B7x and found that the clone 1H3 significantly inhibited growth of B7x-expressing tumors in vivo via multiple mechanisms. Furthermore, the surviving mice given 1H3 treatment were resistant to tumor rechallenge. Our data suggest that targeting B7x on tumors is a promising cancer immunotherapy and humanized 1H3 may be efficacious for immunotherapy of human cancers.

Structure and cancer immunotherapy of the B7 family member B7x.,Jeon H, Vigdorovich V, Garrett-Thomson SC, Janakiram M, Ramagopal UA, Abadi YM, Lee JS, Scandiuzzi L, Ohaegbulam KC, Chinai JM, Zhao R, Yao Y, Mao Y, Sparano JA, Almo SC, Zang X Cell Rep. 2014 Nov 6;9(3):1089-98. doi: 10.1016/j.celrep.2014.09.053. Epub 2014, Oct 30. PMID:25437562^[5]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

References

↑ Salceda S, Tang T, Kmet M, Munteanu A, Ghosh M, Macina R, Liu W, Pilkington G, Papkoff J. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation. Exp Cell Res. 2005 May 15;306(1):128-41. PMID:15878339 doi:http://dx.doi.org/10.1016/j.yexcr.2005.01.018
↑ Kryczek I, Zou L, Rodriguez P, Zhu G, Wei S, Mottram P, Brumlik M, Cheng P, Curiel T, Myers L, Lackner A, Alvarez X, Ochoa A, Chen L, Zou W. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med. 2006 Apr 17;203(4):871-81. Epub 2006 Apr 10. PMID:16606666 doi:http://dx.doi.org/10.1084/jem.20050930
↑ Kryczek I, Wei S, Zhu G, Myers L, Mottram P, Cheng P, Chen L, Coukos G, Zou W. Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. Cancer Res. 2007 Sep 15;67(18):8900-5. PMID:17875732 doi:http://dx.doi.org/10.1158/0008-5472.CAN-07-1866
↑ Miyatake T, Tringler B, Liu W, Liu SH, Papkoff J, Enomoto T, Torkko KC, Dehn DL, Swisher A, Shroyer KR. B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration. Gynecol Oncol. 2007 Jul;106(1):119-27. Epub 2007 May 16. PMID:17509674 doi:http://dx.doi.org/S0090-8258(07)00198-9
↑ Jeon H, Vigdorovich V, Garrett-Thomson SC, Janakiram M, Ramagopal UA, Abadi YM, Lee JS, Scandiuzzi L, Ohaegbulam KC, Chinai JM, Zhao R, Yao Y, Mao Y, Sparano JA, Almo SC, Zang X. Structure and cancer immunotherapy of the B7 family member B7x. Cell Rep. 2014 Nov 6;9(3):1089-98. doi: 10.1016/j.celrep.2014.09.053. Epub 2014, Oct 30. PMID:25437562 doi:http://dx.doi.org/10.1016/j.celrep.2014.09.053

1 Structural highlights
2 Function
3 Publication Abstract from PubMed
4 References

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/4gos"

@@ Line 1: / Line 1: @@
 ==Crystal structure of human B7-H4 IgV-like domain==
-<StructureSection load='4gos' size='340' side='right' caption='[[4gos]], [[Resolution|resolution]] 1.59&Aring;' scene=''>
+<StructureSection load='4gos' size='340' side='right'caption='[[4gos]], [[Resolution|resolution]] 1.59&Aring;' scene=''>
 == Structural highlights ==
-<table><tr><td colspan='2'>[[4gos]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4GOS OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4GOS FirstGlance]. <br>
+<table><tr><td colspan='2'>[[4gos]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4GOS OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4GOS FirstGlance]. <br>
-</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
+</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
-<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4gos FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4gos OCA], [http://pdbe.org/4gos PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4gos RCSB], [http://www.ebi.ac.uk/pdbsum/4gos PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4gos ProSAT]</span></td></tr>
+<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4gos FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4gos OCA], [https://pdbe.org/4gos PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4gos RCSB], [https://www.ebi.ac.uk/pdbsum/4gos PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4gos ProSAT]</span></td></tr>
 </table>
 == Function ==
-[[http://www.uniprot.org/uniprot/VTCN1_HUMAN VTCN1_HUMAN]] Negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. When expressed on the cell surface of tumor macrophages, plays an important role, together with regulatory T-cells (Treg), in the suppression of tumor-associated antigen-specific T-cell immunity. Involved in promoting epithelial cell transformation.<ref>PMID:15878339</ref> <ref>PMID:16606666</ref> <ref>PMID:17875732</ref> <ref>PMID:17509674</ref> [UniProtKB:Q7TSP5]
+[https://www.uniprot.org/uniprot/VTCN1_HUMAN VTCN1_HUMAN] Negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. When expressed on the cell surface of tumor macrophages, plays an important role, together with regulatory T-cells (Treg), in the suppression of tumor-associated antigen-specific T-cell immunity. Involved in promoting epithelial cell transformation.<ref>PMID:15878339</ref> <ref>PMID:16606666</ref> <ref>PMID:17875732</ref> <ref>PMID:17509674</ref> [UniProtKB:Q7TSP5]
 <div style="background-color:#fffaf0;">
 == Publication Abstract from PubMed ==
@@ Line 22: / Line 22: @@
 __TOC__
 </StructureSection>
-[[Category: Almo, S C]]
+[[Category: Homo sapiens]]
-[[Category: Bhosle, R]]
+[[Category: Large Structures]]
-[[Category: IFN, Atoms-to-Animals:.The Immune Function Network]]
+[[Category: Almo SC]]
-[[Category: Structural genomic]]
+[[Category: Bhosle R]]
-[[Category: Nathenson, S G]]
+[[Category: Nathenson SG]]
-[[Category: Ramagopal, U]]
+[[Category: Ramagopal U]]
-[[Category: Toro, R]]
+[[Category: Toro R]]
-[[Category: Vigdorovich, V]]
+[[Category: Vigdorovich V]]
-[[Category: Adaptive immunity]]
-[[Category: Cell surface]]
-[[Category: Disulfide bond]]
-[[Category: Glycoprotein]]
-[[Category: Immune system]]
-[[Category: Immunity]]
-[[Category: Immunoglobulin domain]]
-[[Category: Immunoglobulin variable-like domain]]
-[[Category: Nysgrc]]
-[[Category: PSI, Protein structure initiative]]
-[[Category: Psi-biology]]

4gos

From Proteopedia

Current revision

Crystal structure of human B7-H4 IgV-like domain

Structural highlights

Function

Publication Abstract from PubMed

References

Contents

Proteopedia Page Contributors and Editors (what is this?)

Views

Personal tools

Navigation

Search

Toolbox